AIP
BNR

Almanack Investment Partners’s Burning Rock Biotech BNR Stock Holding History

Almanack Investment Partners’s Portfolio BNR Stock Details BNR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$136K Buy
+16,198
New +$229K 0.02% 308

Other funds holding BNR

Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Almanack Investment Partners's BNR Position: Q2 2026 in Review

Almanack Investment Partners opened a new position in Burning Rock Biotech (BNR) in Q2 2026: 16,198 shares worth $136K. The stake represents 0.02% of the portfolio and ranks #308 among its holdings.

3 funds tracked by Wall St. Rank hold BNR as of Q2 2026.

  • Almanack Investment Partners held 16,198 shares of Burning Rock Biotech worth $136K as of Q2 2026.
  • Burning Rock Biotech was a new Almanack Investment Partners position in Q2 2026.
  • Burning Rock Biotech made up 0.02% of Almanack Investment Partners's portfolio in Q2 2026, its #308 holding.
  • 3 funds tracked by Wall St. Rank held Burning Rock Biotech as of Q2 2026.

Based on Almanack Investment Partners's 13F filing for Q2 2026, filed 30 Jul 2026.